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Lung exposure to inhaled particulate matter may injure the epithelial tissue and lead to a loss of function in 
affected regions via inflammation for example. Screening for the critical contaminate concentrations may provide 
essential information towards damage assessment and epithelial healing. To date, most approaches have 
typically relied on traditional in vitro well plate assays or alternatively in vivo animal experiments. Yet, such 
methods manifest some outstanding disadvantages such as the inability to capture physiological flow and 
aerosol deposition characteristics as well as significant differences in anatomy, immune system and 
inflammatory responses compared to humans. The advent of organ-on-chip platforms has shown promising 
results to reconcile many such drawbacks. In an attempt to provide an attractive in vitro gateway to monitor 
airway health, we discuss here a novel biomimetic platform which emulates the bronchial epithelium of a human 
upper airway, allowing to study organ-level characteristics in a homeostatic cellular microenvironment. This 
device reconstitutes a multi-generation pulmonary epithelial airway environment, capturing realistic respiratory 
transport phenomena and critical cellular barrier functions at an air-liquid interface (ALI), in analogy to the 
bronchial lumen. As a proof of concept, we demonstrate its feasibility for in vitro based assays by exposing the 
device to cytotoxic aerosolized particles under respiratory flow conditions. Subsequently, we investigate the 
cytotoxic effects of these particles including cellular viability, cytokine and mucus secretion as a function of local 
particle deposition patterns. Ultimately, our bronchial airway models are intended to provide off-the-shelf in vitro 
kits geared for the end-user interested in a wide range of broader biological assays that may be attractive for 






Figure 1: (a) Computer-aided drawing (CAD) of our model depicting a multi-generation airway tree, a PET 
membrane bonded with a transparency film that sits on a medium reservoir. (b) View of the whole device. 
(c) Calu-3 cells cultured at an ALI within the device: view of the entire tree (upper), the first bifurcation (bottom 
left) and the third branch (bottom right) of the structure (cells stained green for F-actin and blue for cell nuclei). 
 
